UBS Group Forecasts Strong Price Appreciation for BrightSpring Health Services (NASDAQ:BTSG) Stock

BrightSpring Health Services (NASDAQ:BTSGGet Free Report) had its price target lifted by equities research analysts at UBS Group from $53.00 to $55.00 in a note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group’s price target indicates a potential upside of 25.07% from the company’s current price.

Other equities research analysts also recently issued reports about the company. BTIG Research reissued a “buy” rating and issued a $55.00 target price on shares of BrightSpring Health Services in a report on Monday, March 2nd. BMO Capital Markets reaffirmed an “outperform” rating and issued a $46.00 price target on shares of BrightSpring Health Services in a research report on Friday, January 23rd. TD Cowen reiterated a “buy” rating on shares of BrightSpring Health Services in a research note on Monday, March 2nd. Stephens started coverage on shares of BrightSpring Health Services in a research report on Wednesday, December 10th. They set an “overweight” rating and a $44.00 price objective on the stock. Finally, Bank of America raised their price objective on shares of BrightSpring Health Services from $38.00 to $41.00 and gave the company a “buy” rating in a research note on Tuesday, December 9th. Two research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $45.50.

Read Our Latest Stock Report on BrightSpring Health Services

BrightSpring Health Services Price Performance

BTSG stock opened at $43.98 on Wednesday. The company has a debt-to-equity ratio of 1.32, a quick ratio of 1.12 and a current ratio of 1.57. The firm has a 50 day moving average price of $39.95 and a 200-day moving average price of $34.98. BrightSpring Health Services has a 52-week low of $15.48 and a 52-week high of $44.87. The firm has a market capitalization of $8.51 billion, a price-to-earnings ratio of 49.97, a PEG ratio of 0.57 and a beta of 2.31.

BrightSpring Health Services (NASDAQ:BTSGGet Free Report) last posted its quarterly earnings results on Friday, February 27th. The company reported $0.33 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.01). BrightSpring Health Services had a return on equity of 12.66% and a net margin of 1.48%.The company had revenue of $3.55 billion during the quarter, compared to analysts’ expectations of $3.38 billion. During the same quarter in the previous year, the company earned $0.11 EPS. The business’s quarterly revenue was up 29.3% on a year-over-year basis. Equities research analysts forecast that BrightSpring Health Services will post 0.59 EPS for the current fiscal year.

Insider Transactions at BrightSpring Health Services

In related news, insider Lisa A. Nalley sold 30,000 shares of BrightSpring Health Services stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $41.15, for a total value of $1,234,500.00. Following the completion of the sale, the insider directly owned 110,594 shares in the company, valued at approximately $4,550,943.10. This trade represents a 21.34% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jon B. Rousseau sold 220,000 shares of the business’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $41.15, for a total value of $9,053,000.00. Following the completion of the transaction, the insider directly owned 1,023,880 shares of the company’s stock, valued at approximately $42,132,662. This trade represents a 17.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 285,000 shares of company stock worth $11,727,750 over the last quarter. 3.40% of the stock is currently owned by insiders.

Institutional Trading of BrightSpring Health Services

Institutional investors have recently made changes to their positions in the stock. Lisanti Capital Growth LLC purchased a new stake in BrightSpring Health Services in the third quarter worth approximately $1,959,000. Federated Hermes Inc. raised its stake in BrightSpring Health Services by 44.8% during the 3rd quarter. Federated Hermes Inc. now owns 319,200 shares of the company’s stock valued at $9,436,000 after buying an additional 98,745 shares during the last quarter. Prescott Group Capital Management L.L.C. bought a new position in shares of BrightSpring Health Services during the 3rd quarter valued at $887,000. Ellsworth Advisors LLC bought a new position in shares of BrightSpring Health Services during the 3rd quarter valued at $983,000. Finally, Bailard Inc. purchased a new position in shares of BrightSpring Health Services in the 3rd quarter worth $378,000.

More BrightSpring Health Services News

Here are the key news stories impacting BrightSpring Health Services this week:

  • Positive Sentiment: Multiple brokerages raised price targets and reiterated buy/outperform ratings (UBS raised to $55; BTIG reaffirmed buy with $55 PT; Mizuho raised to $52), providing fresh analyst support and upside to current levels. Broker Upgrades
  • Positive Sentiment: Recent price momentum flagged in market coverage — Zacks noted a 7.8% intraday jump and positive earnings-estimate revision trends, which can attract momentum and quant buyers. BTSG Moves 7.8% Higher
  • Positive Sentiment: Company segment results highlighted as strong — coverage points to particularly strong Q4 performance in Senior Health, Home Health & Hospice, supporting revenue growth narrative that already showed a year-over-year lift. Q4 Segment Strength
  • Neutral Sentiment: Investor/analyst day transcript released — useful for detail on strategy, margins and growth outlook but neutral until management provides new guidance or specifics that change estimates. Analyst/Investor Day Transcript
  • Neutral Sentiment: Valuation comparison piece (BTSG vs. ALHC) examines whether BTSG is the better value — informational for investors weighing alternatives but not an immediate catalyst. Value Comparison
  • Neutral Sentiment: Inclusion on lists of stocks showing price strength amid market stress signals relative strength/market interest, which can support further flows but is not a guaranteed driver. Price Strength Mention
  • Neutral Sentiment: Short-interest report appears inconsistent/erroneous (shows a “significant increase” headline but records 0 shares and NaN changes) — if genuine short interest rises it could add volatility, but current data looks unreliable and should be confirmed.

About BrightSpring Health Services

(Get Free Report)

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.

Further Reading

Analyst Recommendations for BrightSpring Health Services (NASDAQ:BTSG)

Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.